A recent study suggests that patients who come off blockbuster slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who stop conventional lifestyle regimens.
Findings released in a prominent medical journal demonstrates that while overweight individuals frequently drop about a fifth of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"People purchasing these drugs must be aware of the danger of quick weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to original mass within about 18 months.
Comparing Therapies
The analysis, which looked at dozens of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers point out that individuals who shed pounds through dieting generally have a more gradual weight regain—approximately 100 grams monthly—once they finish.
Explaining the Fast Rebound
Nutrition scientists believe the mode of action of the drugs accounts for the amplified regain.
The injections copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of the hormone concentrations far above than normal might result in the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication results in appetite is uncontrolled, making overeating a significant risk."
A Lifelong Condition?
The NHS advise the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Professionals argue that, considering the high risk of weight regain, the treatment should be considered ongoing.
This view is supported by drug manufacturers, who state that the results "emphasize the persistent character of excess weight," similar to managing conditions like hypertension.
Patient Accounts
Individuals who have come off the jabs describe a intense resurgence of cravings.
"I experienced something activating and you become extremely hungry," described one woman.
This challenge is exacerbated if individuals have not established permanent lifestyle or habit modifications during therapy.
Widespread Adoption
Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Use is more common among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, researchers caution that while these medications are potent tools for shedding pounds, they are not a permanent solution and long-term success relies on combined lifestyle management.
